Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -116.09MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 101.52Close
$ 11.15 - $ 116.15 52-Week Range
Ticker Information
Ticker
CDTXCompany Name
CIDARA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCIDARA THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CDTX - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 1.4M | $ -117.49M | $ -116.09M |
| 3/31/2025 | $ 1.39M | $ -182.98M | $ -181.59M |
| 12/31/2024 | $ 1.28M | $ -169.83M | $ -168.55M |
| 9/30/2024 | $ 1.2M | $ -123.07M | $ -121.86M |
| 6/30/2024 | $ 1.13M | $ -115.02M | $ -113.89M |
| 3/31/2024 | $ 1.49M | $ -36.65M | $ -35.16M |
| 12/31/2023 | $ 1.28M | $ -22.49M | $ -21.21M |
| 9/30/2023 | $ 1.03M | $ -31.06M | $ -30.03M |
| 6/30/2023 | $ 787K | $ -8.2M | $ -7.41M |
| 3/31/2023 | $ 136K | $ -8.48M | $ -8.34M |
Key Performance Insights, Last 5 Years
- CIDARA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -64.23M.
- Over the past 5 years, CIDARA THERAPEUTICS INC's average EBITDA has been $ -66.06M.
- The median EBITDA for CIDARA THERAPEUTICS INC during this period was $ -46.55M
- CIDARA THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -7.41M.
- The lowest EBITDA recorded by CIDARA THERAPEUTICS INC in the same timeframe $ -181.59M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for CIDARA THERAPEUTICS INC is calculated as follows: EBIT [ $ -64.52M ] + DepAmor [ $ 296K ]
(=) EBITDA [ $ -64.23M ] CDTX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -181.59M
Minimum
Mar 31, 2025
$ -7.41M
Maximum
Jun 30, 2023
$ -66.06M
Average
$ -46.55M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.79M |
| median | $ 8.83M |
| std | $ 166.94M |